Treatment of obesity

Mayo Clinic Proceedings

Volumn 82, Issue 1, 2007, Pages 93-102

  Thompson, Warren G ^a   Cook, David A ^a   Clark, Matthew M ^a   Bardia, Aditya ^a   Levine, James A ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; BENZPHETAMINE; FENFLURAMINE; PHENDIMETRAZINE; PHENTERMINE; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TOPIRAMATE;

AGEUSIA; ANXIETY; BARIATRIC SURGERY; BEHAVIOR; BLOOD PRESSURE; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DIET; ENERGY ABSORPTION; EXERCISE; HEART PALPITATION; HEART RATE; HUMAN; OBESITY; PARESTHESIA; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; REVIEW; SELF MONITORING; SIDE EFFECT; SOCIAL SUPPORT; THERMOGENESIS; TREATMENT INDICATION; VALVULAR HEART DISEASE; WEIGHT REDUCTION;

EID: 33845928553     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.1.93     Document Type: Review

References (96)

1. Allison DB, Fontaine KR, Manson JE, Stevens J, Vanltallie TB. Annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530-1538.
2. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293:1861-1867.
3. Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc. 1999;31(11, suppl):S663-S667.
4. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
5. Stafford RS, Radley DC. National trends in antiobesity medication use. Arch Intern Med. 2003;163:1046-1050.
6. Ruser CB, Sanders L, Brescia GR, et al. Identification and management of overweight and obesity by internal medicine residents. J Gen Intern Med. 2005;20:1139-1141.
7. Yusuf S, Hawken S, Ounpuu S, et al, INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640-1649.
8. McArtor RE, Iverson DC, Benken D, Dennis LK. Family practice residents' identification and management of obesity. Int J Obes Relat Metab Disord. 1992;16:335-340.
9. Wadden TA, Foster GD. Behavioral treatment of obesity. Med Clin North Am. 2000;84:441-461.
10. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293:43-53.
11. Foster GD, Wyatt HR, Hill JO, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003;348:2082-2090.
12. Stern L, Iqbal N, Seshadri P, et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med. 2004;140:778-785.
13. Slabber M, Barnard HC, Kuyl JM, Dannhauser A, Schall R. Effects of a low-insulin-response, energy-restricted diet on weight loss and plasma insulin concentrations in hyperinsulinemic obese females. Am J Clin Nutr. 1994;60: 48-53.
14. Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP, Ludwig DS. A reduced-glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med. 2003;157:773-779.
15. Thompson WG, Rostad Holdman N, Janzow DJ, Slezak JM, Morris KL, Zemel MB. Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. Obes Res. 2005;13:1344-1353.
16. Raatz SK, Torkelson CJ, Redmon JB, et al. Reduced glycemic index and glycemic load diets do not increase the effects of energy restriction on weight loss and insulin sensitivity in obese men and women. J Nutr. 2005;135:2387-2891.
17. Due A, Toubro S, Skov AR, Astrup A. Effect of normal-fat diets, either medium or high in protein, on body weight in overweight subjects: a randomised 1-year trial. Int J Obes Relat Metab Disord. 2004;28:1283-1290.
18. Howard BV, Manson JE, Stefanick ML, et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA. 2006;295:39-49.
19. Klem ML, Wing RR, McGuire MT, Seagle HM, Hill JO. A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr. 1997;66:239-246.
20. Schlundt DG, Hill JO, Pope-Cordle J, Arnold D, Virts KL, Katahn M. Randomized evaluation of a low fat ad libitum carbohydrate diet for weight reduction. Int J Obes Relat Metab Disord. 1993;17:623-629.
21. Rolls BJ, Roe LS, Meengs JS. Reductions in portion size and energy density of foods are additive and lead to sustained decreases in energy intake. Am J Clin Nutr. 2006;83:11-17.
22. Rolls BJ, Roe LS, Beach AM, Kris-Etherton PM. Provision of foods differing in energy density affects long-term weight loss. Obes Res. 2005;13: 1052-1060.
23. Wadden TA, Berkowitz RI, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353: 2111-2120.
24. Haddock CK, Poston WS, Dill PL, Foreyt JP, Ericsson M. Pharmacotherapy for obesity: a quantitative analysis of four decades of randomized clinical trials. Int J Obes Relat Metab Disord. 2002;26:262-273.
25. DeWald T, Khaodhiar L, Donahue MP, Blackburn G. Pharmacological and surgical treatments for obesity. Am Hear J. 2006;151:604-624.
26. Arterburn DE, Crane PK, Veenstra DL. The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med. 2004;164: 994-1003.
27. Li Z, Maglione M, Tu, W, at al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005;142:532-546.
28. Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S, RIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study [published correction appears in Lancet. 2005;366:370]. Lancet. 2005;365:1389-1397.
29. Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, RIO-North America Study Group. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial [published correction appears in JAMA. 2006;295:1252]. JAMA. 2006;295:761-775.
30. Simons-Morion DG, Obarzanek E, Cutler JA. Obesity research-limitations of methods, measurements, and medications [editorial]. JAMA. 2006;295: 826-828.
31. Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial [published correction appears in JAMA 1999;281: 1174]. JAMA. 1999;281:235-242.
32. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients [published correction appears in Diabetes Care. 2004;27: 856]. Diabetes Care. 2004;27:155-161.
33. Zelber-Sagi S, Kessler A, Brazowsky E, et al. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2006 May;4:639-644. Epub 2006 Apr 17.
34. Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Arnold ME, Steinberg CM. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial. Obes Res. 2000;8:431-437.
35. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909-1917.
36. Wolfe BM, Morton JM. Weighing in on bariatric surgery: procedure use, readmission rates, and mortality [editorial]. JAMA. 2005;294:1960-1963.
37. Sjöström L, Lindroos AK, Peltonen M, et al, Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.
38. Pories WJ, MacDonald KG Jr, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr. 1992;55(2, suppl):582S-585S.
39. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis [published correction appears in JAMA. 2005;293:1728]. JAMA. 2004;292:1724-1737.
40. Zingmond DS, McGory ML, Ko CY. Hospitalization before and after gastric bypass surgery. JAMA. 2005;294:1918-1924.
41. Abell TL, Minocha A. Gastrointestinal complications of bariatric surgery: diagnosis and therapy. Am J Med Sci. 2006;331:214-218.
42. Malinowski SS. Nutritional and metabolic complications of bariatric surgery. Am J Med Sci. 2006;331:219-225.
43. Paxton JH, Matthews JB. The cost effectiveness of laparoscopic versus open gastric bypass surgery. Obes Surg. 2005;15:24-34.
44. Snow LL, Weinstein LS, Hannon JK, et al. The effect of Roux-en-Y gastric bypass on prescription drug costs. Obes Surg. 2004;14:1031-1035.
45. Clegg A, Colquitt J, Sidhu M, Royle P, Walker A. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord. 2003;27:1167-1177.
46. Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med. 2002;113:491-498.
47. Clark MM, Balsiger BM, Sletten CD, et al. Psychosocial factors and 2-year outcome following bariatric surgery for weight loss. Obes Surg. 2003;13: 739-745.
48. Busetto L, Segato G, DeLuca M, et al. Weight loss and postoperative complications in morbidly obese patients with binge eating disorder treated by laparoscopic adjustable gastric banding. Obes Surg. 2005;15: 195-201.
49. Buddeberg-Fischer B, Klaghofer R, Krug L et al. Physical and psychosocial outcome in morbidly obese patients with and without bariatric surgery: a 4 1/2-year follow-up. Obes Surg. 2006;16:321-330.
50. Bensimhon DR, Kraus WE, Donahue MP. Obesity and physical activity: a review. Am Heart J. 2006;151:598-603.
51. Curioni CC, Lourenço PM. Long-term weight loss after diet and exercise: a systematic review. Int J Obes (Lond). 2005;29:1168-1174.
52. Ross R, Dagnone D, Jones PJ et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, controlled trial. Ann Intern Med. 2000;133:92-103.
53. Bouchard C, Tremblay A, Nadeau A et al. Long-term exercise training with constant energy intake, 1: effect on body composition and selected metabolic variables [published correction appears in Int J Obes. 1990;14:987]. Int J Obes. 1990;14:57-73.
54. Jakicic JM, Marcus BH, Gallagher KI, Napolitano M, Lang W. Effect of exercise duration and intensity on weight loss in overweight, sedentary women: a randomized trial. JAMA. 2003;290:1323-1330.
55. DePue JD, Clark MM, Ruggiero L, Medeiros ML, Pera V Jr. Maintenance of weight loss: a needs assessment. Obes Res. 1995;3:241-248.
56. Andersen RE, Crespo CJ, Bartlett SJ, Cheskin LJ, Pratt M. Relationship of physical activity and television watching with body weight and level of fatness among children: results from the Third National Health and Nutrition Examination Survey. JAMA. 1998;279:938-942.
57. Stemfeld B, Wang H, Quesenberry CP Jr. et al. Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health Across the Nation. Am J Epidemiol. 2004;0:912-922.
58. Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr. 2001;21:323-341.
59. Kraemer WJ, Volek JS, Clark KL et al. Influence of exercise training on physiological and performance changes with weight loss in men. Med Sci Sports Exerc. 1999;31:1320-1329.
60. Foster G. The behavioral approach to treating obesity. Am Heart J. 2006; 151:625-627.
61. Levine JA. Nonexercise activity thermogenesis (NEAT): environment and biology [published correction appears in Am J Physiol Endocrinol Metab. 2004;288:E285]. Am J Physiol Endocrinol Metab. 2004;286:E675-E685.
62. Lanningham-Foster L, Nysse LJ, Levine JA. Labor saved, calories lost: the energetic impact of domestic labor-saving devices. Obes Res. 2003;11:1178-1181.
63. Haskell WL. Physical activity, sport, and health: toward the next century. Res Q Exerc Sport. 1996;67(3, suppl):S37-S47.
64. Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. JAMA. 1986;256:51-54.
65. Stunkard AJ, Sorensen TI, Hanis C, et al. An adoption study of human obesity. N Engl J Med. 1986;314:193-198.
66. de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R. Resting energy expenditure, cardiovascular risk factors and insulin resistance in obese patients. Ann Nutr Metab. 2005 Nov-Dec;49:381-385. Epub 2005 Oct 11.
67. Bouchard C, Tremblay A, Després JP, et al. The response to long-term overfeeding in identical twins. N Engl J Med. 1990;322:1477-1482.
68. Weinsier RL, Hunter GR, Desmond RA, Byrne NM, Zuckerman PA, Damell BE. Free-living activity energy expenditure in women successful and unsuccessful at maintaining a normal body weight. Am J Clin Nutr. 2002;75:499-504.
69. Levine JA, Eberhardt NL, Jensen MD. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science. 1999;283:212-214.
70. Levine JA, Schleusner SJ, Jensen MD. Energy expenditure of nonexercise activity. Am J Clin Nutr. 2000;72:1451-1454.
71. Levine JA, Lanningham-Foster LM, McCrady SK, et al. Interindividual variation in posture allocation: possible role in human obesity. Science. 2005;307:584-586.
72. Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff (Millwood). 2002;21:245-253.
73. Schmeichel BJ, Baumeister RF. Self-regulatory strength. In: Baumeister RF, Vohs KD, eds. Handbook of Self-Regulation: Research, Theory, and Applications. New York, NY: Guilford Press; 2004:84-98.
74. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep. 2005;28:1289-1296.
75. Mischel W, Shoda Y, Rodriguez MI. Delay of gratification in children. Science. 1989;244:933-938.
76. Metcalfe J, Mischel W. A hot/cool-system analysis of delay of gratification: dynamics of willpower. Psychol Rev. 1999;106:3-19.
77. Shaw K, O'Rourke P, Del Mar C, Kenardy J. Psychological interventions for overweight or obesity. Cochrane Database Syst Rev. 2005 Apr 18;2:CD003818.
78. Foreyt JP, Goodrick GK. Evidence for success of behavior modification in weight loss and control. Ann Intern Med. 1993;119(7, pt 2):698-701.
79. Guare JC, Wing RR, Marcus MD, Epstein LH, Burton LR, Gooding WE. Analysis of changes in eating behavior and weight loss in type II diabetic patients: which behaviors to change. Diabetes Care. 1989;12:500-503.
80. Pereira MA, Kartashov AI, Ebbeling CB, et al. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis [published correction appears in Lancet. 2005;365:1030]. Lancet. 2005 365:36-42.
81. Bes-Rastrollo M, Sánchez-Villegas A, Gómez-Gracia E, Martínez JA, Pajares RM, Martínez-González MA. Predictors of weight gain in a Mediterranean cohort: the Seguimiento Universidad de Navarra Study. Am J Clin Nutr. 2006;83:362-370.
82. Borushek A. The Doctor's Pocket Calorie, Fat and Carbohydrate Counter. Costa Mesa, Calif: Family Health Publications; 2001.
83. McDonald's USA nutrition facts for popular menu items. Available at: www.mcdonalds.com/app_controller.nutrition.index1.html. Accessed November 15, 2006.
84. Cervone D, Mor N, Orom H, Shadel WG, Scott WD. Self-efficacy beliefs and the architecture of personality: on knowledge, appraisal, and self-regulation. In: Baumeister RF, Vohs KD, eds. Handbook of Self-Regulation: Research, Theory, and Applications. New York, NY: Guilford Press; 2004:188-210.
85. Gollwitzer PM, Fujita K, Oettingen G. Planning and the implementation of goals. In: Baumeister RF, Vohs KD. Handbook of Self-Regulation: Research, Theory, and Applications. New York, NY: Guilford Press: 2004: 211-228.
86. Bandura A. Self-Efficacy: The Exercise of Control. New York, NY: WH Freeman; 1997.
87. Clark MM, Abrahms DB, Niaura RS, Eaton CA, Rossi JS. Self-efficacy in weight management. J Consult Clin Psychol. 1991;59:739-744.
88. Pinto BM, Clark MM, Cruess DG, Szymanski L, Pera V. Changes in self-efficacy and decisional balance for exercise among obese women in a weight management program. Obes Res. 1999;7:288-292.
89. Carver CS. Self-regulation of action and affect. In: Baumeister RF, Vohs KD. Handbook of Self-Regulation: Research, Theory, and Applications. New York, NY: Guilford Press; 2004:13-39.
90. Verheijden MW, Bakx JC, van Weel C, Koelen MA, van Staveren WA. Role of social support in lifestyle-focused weight management interventions. Eur J Clin Nutr. 2005;59(suppl 1):S179-S186.
91. Gallagher KI, Jakicic JM, Napolitano MA, Marcus BH. Psychosocial factors related to physical activity and weight loss in overweight women. Med Sci Sports Exerc. 2006;38:971-980.
92. Herman CP, Polivy J. The self-regulation of eating: theoretical and practical problems. In: Baumeister RF, Vohs KD. Handbook of Self-Regulation: Research, Theory, and Applications. New York, NY: Guilford Press; 2004:492-508.
93. Rothman AJ, Baldwin AS, Hertel AW. Self-regulation and behavior change: disentangling behavioral initiation and behavioral maintenance. In: Baumeister RF, Vohs KD. Handbook of Self-Regulation: Research, Theory, and Applications. New York, NY: Guilford Press; 2004:130-148.
94. Brownell KD. The Learn Program for Weight Management 2000. Dallas, Tex: American Health Publishing; 2000.
95. Schuckit MA. Inpatient and residential approaches to the treatment of alcoholism. In: Mendelson JH, Mello NK, eds: Medical Diagnosis and Treatment of Alcoholism. New York, NY: McGraw-Hill; 1992:393-420.
96. Hull JG, Slone LB. Alcohol and self-regulation. In: Baumeister RF, Vohs KD. Handbook of Self-Regulation: Research, Theory, and Applications. New York, NY: Guilford Press; 2004:466-491.